
Labcorp Expands Oncology Testing
Summary Labcorp is acquiring BioReference Health’s oncology and oncology-related clinical testing assets for $225 million. This acquisition expands Labcorp’s cancer diagnostic portfolio and strengthens its position in the growing oncology market. The deal is expected […]